Fava, C., Kantarjian, H., Cortes, J., & Jabbour, E. (2009). Development and targeted use of nilotinib in chronic myeloid leukemia. Dove Medical Press.
Chicago Style CitationFava, Carmen, Hagop Kantarjian, Jorge Cortes, i Elias Jabbour. Development and Targeted Use of Nilotinib in Chronic Myeloid Leukemia. Dove Medical Press, 2009.
Cita MLAFava, Carmen, Hagop Kantarjian, Jorge Cortes, i Elias Jabbour. Development and Targeted Use of Nilotinib in Chronic Myeloid Leukemia. Dove Medical Press, 2009.
Atenció: Aquestes cites poden no estar 100% correctes.